A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants with Congenital Adrenal Hyperplasia Including a Long-Term Extension
2026-09-14
عنوان الدراسة
A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants with Congenital Adrenal Hyperplasia Including a Long-Term Extension
داعم الدراسة
Crinetics Pharmaceuticals, Inc.
دواء الدراسة
atumelnant/ CRN04894
رقم بروتوكول الدراسة
CRN04894-13
حالة الدراسة
Ongoing
موقع الدراسة
1.King Saud University Medical City -Riyadh 2. King Faisal Specialist Hospital and Research Center - Riyadh
مرحلة الدراسة
2/3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.